Current-induced magnetic tomography market seen reaching $70 million by 2030

The current-induced magnetic tomography market is projected to grow from $50 million in 2025 to $70 million by 2030, driven by demand for non-invasive imaging and cancer diagnostics. North America led the market in 2025, while Western Europe is expected to be the fastest-growing region.

Why it matters: - Current-induced magnetic tomography, or CIMT, is positioned as a radiation-free imaging option that can map electrical conductivity and current density inside biological tissues. - The market outlook points to steady growth in a niche part of medical imaging, with demand tied to earlier diagnosis, functional tissue imaging and oncology use cases. - The technology could expand beyond structural imaging into real-time tissue characterization and personalized diagnostics.

What happened: - The current-induced magnetic tomography market was valued at $0.05 billion in 2025 and is projected to remain at $0.05 billion in 2026, with a 6.8% CAGR over the historical period. - The market is forecast to reach $0.07 billion by 2030, with a 7.1% CAGR during the forecast period. - The Business Research Company released the outlook in its 2026 market report. - More information is available through a free sample request. - The full report is available online.

The details: - CIMT combines bio-impedance and magnetic methods to map electrical conductivity and current density inside biological tissues. - The technique detects secondary magnetic fields produced by injected or induced electrical currents. - The method provides functional and structural information about cellular health, tissue perfusion and electrical properties. - Growth in the market has been supported by rising demand for non-invasive diagnostic imaging, wider adoption of advanced medical imaging technologies, more chronic disease cases, higher biomedical research investment and expanding healthcare imaging infrastructure. - Future growth is expected to be supported by rising demand for functional tissue imaging, greater use of AI-based image interpretation, more emphasis on personalized diagnostics, advances in bioelectromagnetic imaging research and higher investment in next-generation imaging solutions. - Key future trends include broader adoption of non-invasive functional imaging, better magnetic field detection systems, integration of electrical conductivity mapping into diagnosis, more real-time tissue characterization and stronger interest in radiation-free alternatives. - The report also highlights market attractiveness scoring, total addressable market analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics, key technology analysis and updated graphics and tables.

Between the lines: - CIMT remains an emerging market, and the projected dollar values are still small relative to mainstream imaging categories. - The strongest demand signals come from two large clinical needs: safer imaging and better tumor detection. - Rising cancer prevalence strengthens the case for technologies that can support diagnosis and treatment planning without radiation exposure. - NHS data showing brain MRI referrals from general practitioners rising from 8,695 in January 2022 to 8,745 in January 2023 points to continued reliance on non-invasive imaging. - The American Cancer Society estimated about 20.6 million new cancer cases globally in 2024, excluding nonmelanoma skin cancer, along with 9.8 million cancer-related deaths.

What's next: - North America held the largest market share in 2025. - Western Europe is expected to be the fastest-growing region during the forecast period. - Asia-Pacific, Southeast Asia, Eastern Europe, South America, the Middle East and Africa remain part of the broader global market landscape. - Ongoing work in magnetic field detection, conductivity mapping and AI interpretation will likely shape whether CIMT moves from niche research into broader clinical adoption.